Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Latex Hypersensitivity D020315 1 associated lipids
Stroke D020521 32 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Coronary Stenosis D023921 6 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Dyslipidemias D050171 7 associated lipids
Atherosclerosis D050197 85 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Izaki S et al. Platelet-activating factor and arachidonic acid metabolites in psoriatic inflammation. 1996 Br. J. Dermatol. pmid:8763425
Fuse I et al. Vascular thromboxane formation in hemostasis mechanism: correlation between bleeding time and vascular TXB2 in a patient with congenital platelet cyclo-oxygenase deficiency. 1996 Int. J. Hematol. pmid:8762815
Kuroiwa M et al. Effects of granulocyte colony-stimulating factor on the hemostatic system in healthy volunteers. 1996 Int. J. Hematol. pmid:8762814
Xiao J et al. [Effects of platelet activating factor and platelet activating factor receptor antagonist on spinal cord blood flow after spinal cord injury]. 1995 Zhonghua Wai Ke Za Zhi pmid:8762548
Zhang M et al. [Reduction of incidence of ischemia-reperfusion induced ventricular fibrillation by captopril]. 1995 Sheng Li Xue Bao pmid:8762446
Yan GT et al. [Tumor necrosis factor induced enhancement of neutrophil chemotaxis and adhesion through mediating of phospholipase A2 activation]. 1995 Sheng Li Xue Bao pmid:8762444
Fimognari FL et al. Associated daily biosynthesis of cortisol and thromboxane A2: a preliminary report. 1996 J. Lab. Clin. Med. pmid:8759943
Hibi S et al. Structure-activity relationships of (E)-3-(1,4-benzoquinonyl)-2-[(3-pyridyl)-alkyl]-2-propenoic acid derivatives that inhibit both 5-lipoxygenase and thromboxane A2 synthetase. 1996 J. Med. Chem. pmid:8759636
Janabi N et al. Endogenous nitric oxide activates prostaglandin F2 alpha production in human microglial cells but not in astrocytes: a study of interactions between eicosanoids, nitric oxide, and superoxide anion (O2-) regulatory pathways. 1996 J. Immunol. pmid:8757337
Mito Y [Thromboxane B2 (TXB2)]. 1995 Nippon Rinsho pmid:8753342
Gu YJ et al. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery. 1996 J. Thorac. Cardiovasc. Surg. pmid:8751518
Yokoyama I et al. Liberation of vasoactive substances and its prevention with thromboxane A2 synthase inhibitor in pig liver transplantation. 1996 Transpl. Int. pmid:8748415
Mathie RT et al. The haemodynamic effects of the thromboxane A2 receptor antagonist GR32191B during cardiopulmonary bypass in the dog. 1995 Perfusion pmid:8747897
Yoshida T et al. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904. 1996 Lupus pmid:8743126
Yang JM et al. Sodium nonivamide acetate: a non-pungently antinociceptive capsaicin derivative with unusual anti-inflammatory properties. 1996 Gen. Pharmacol. pmid:8742512
Laffi G et al. Defective aggregation in cirrhosis is independent of in vivo platelet activation. 1996 J. Hepatol. pmid:8738730
Young JM et al. Human whole blood assays for inhibition of prostaglandin G/H synthases-1 and -2 using A23187 and lipopolysaccharide stimulation of thromboxane B2 production. 1996 Inflamm. Res. pmid:8737748
Ravn HB et al. Magnesium inhibits human platelets. 1996 Blood Coagul. Fibrinolysis pmid:8735829
Lechi C et al. In vitro study of the anti-aggregating activity of two nitroderivatives of acetylsalicylic acid. 1996 Blood Coagul. Fibrinolysis pmid:8735820
Jancinová V et al. Inhibition of blood platelet functions by cationic amphiphilic drugs in relation to their physico-chemical properties. 1996 Blood Coagul. Fibrinolysis pmid:8735816
Cheng Z et al. Pharmacokinetics and pharmacodynamics of phenylbutazone and oxyphenbutazone in the donkey. 1996 J. Vet. Pharmacol. Ther. pmid:8735424
Li H [Research on plasma TXA2, PGI2 levels, blood stasis syndrome and promoting blood circulation]. 1995 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8732157
Liang-min LD et al. [Effect of age on hemostasis and plasma level of TXB2 and 6-keto-PGF1 alpha]. 1995 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8732148
Liang XC et al. [Study on relationship of lipid peroxide in coronary heart disease with and without diabetes]. 1996 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8732128
Xiong YL and Zhao HY Experimental studies on preventive effects of API0134 on vessel reocclusion after thrombolysis. 1995 J. Tongji Med. Univ. pmid:8731957
Xiong YL and Zhao HY Effect of captopril on antithrombus function of endothelium. 1995 J. Tongji Med. Univ. pmid:8731927
Isozaki H et al. Urinary thromboxane B2 as an indicator of acute rejection in human liver transplantation. 1996 Surg. Today pmid:8727944
Grauer GF et al. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs. 1996 Am. J. Vet. Res. pmid:8725828
Yanase T et al. Dibutyryl cAMP improves systemic vasoconstriction caused by endotoxin in dogs. 1996 Shock pmid:8721389
Kruse-Elliott KT et al. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist. 1996 Shock pmid:8721386
Oláh L et al. [Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke]. 1996 Orv Hetil pmid:8714038
Tishler M et al. Salivary eicosanoid concentration in patients with Sjögren's syndrome. 1996 Ann. Rheum. Dis. pmid:8712887
Herrick AL et al. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. 1996 Ann. Rheum. Dis. pmid:8712862
Howarth SR et al. Role of thromboxane A2 in the vasoconstrictor response to endothelin-1, angiotensin II and 5-hydroxytryptamine in human placental vessels. 1995 Placenta pmid:8710799
Liu H et al. [Effects of low dose aspirin on platelet function and prostaglandins metabolism in systemic and coronary circulation in patients with ischemia heart disease]. 1995 Zhonghua Nei Ke Za Zhi pmid:8697924
Sun B et al. [The experimental observation on the procedure of atherosclerotic restenosis following PTCA]. 1995 Zhonghua Nei Ke Za Zhi pmid:8697911
Nosál R et al. The H1-histamine antagonist Dithiaden inhibits human platelets in vitro. 1996 Inflamm. Res. pmid:8696916
Jensen N et al. Recovery of endothelial cells and prostanoid production in endothelial cell-seeded grafts. 1996 Eur J Vasc Endovasc Surg pmid:8696898
Takase B et al. Arachidonic acid metabolites in acute myocardial infarction. 1996 Angiology pmid:8686958
Malý J et al. Migraine--a haematological disorder? 1995 Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove pmid:8685625
Taylor PM et al. Pharmacodynamics and enantioselective pharmacokinetics of carprofen in the cat. 1996 Res. Vet. Sci. pmid:8685536
Cervar M et al. Altered release of endothelin-1,2 and thromboxane B2 from trophoblastic cells in pre-eclampsia. 1996 Eur. J. Clin. Invest. pmid:8682152
Delatour P et al. Pharmacodynamics and chiral pharmacokinetics of carprofen in calves. 1996 Br. Vet. J. pmid:8680841
Tsunomori M et al. 15-Hydroperoxyeicosapentaenoic acid inhibits arachidonic acid metabolism in rabbit platelets more potently than eicosapentaenoic acid. 1996 Biochim. Biophys. Acta pmid:8679681
Myers SI et al. Regulation of eicosanoid synthesis in fibroblasts from inflamed gallbladders. 1995 Mol. Cell. Endocrinol. pmid:8674862
Stein CM et al. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. 1996 Arthritis Rheum. pmid:8670323
Saitta A et al. Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor test. 1995 Jul-Aug Pharmacol. Res. pmid:8668647
Haimovich B et al. The FcgammaRII receptor triggers pp125FAK phosphorylation in platelets. 1996 J. Biol. Chem. pmid:8663117
Wahle KW and Peacock LI Effects of isomeric cis and trans eighteen carbon monounsaturated fatty acids on porcine platelet function. 1996 Biochim. Biophys. Acta pmid:8652649
Dehmlow C et al. Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. 1996 Life Sci. pmid:8649189